Alphina Therapeutics
Redefining precision oncology for ADCs with a novel payload
Westport, United States · Founded 2020 · $40.2M raised
- Headquarters
- Westport, Connecticut
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- alphinatx.com
- Total Funding
- $40.2M
- Last Round
- $154K Venture RoundMar 2026
- Rounds
- 2
About
Biotechnology company developing precision oncology therapies using proprietary biomarkers targeting antibody-drug conjugates and NAD metabolism.
Summary
Alphina Therapeutics is a Biotech company based in Westport, United States, founded in 2020. It has raised $40.2M in total across 2 rounds, most recently a $154K Venture Round round in Mar 2026. Investors include Canaan Partners, Osage University Partners and Connecticut Innovations.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...